Public SEC Form D records
Biotech Series A Form D filings - June 2026
This page lists the 43 matching Form D filings FormDFlow has indexed and tagged from public SEC EDGAR records for Biotech-tagged issuers at a FormDFlow-inferred Series A stage in June 2026 - a filtered subset, not every matching Form D filed, and not a ranked, curated, or recommended selection. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
- Filings
- 43
- Issuers
- 42
- Combined disclosed
- $350.1M
Directory links
Filing records
43 crawlable filing links in this facet.
- FibroBiologics, Inc.June 29, 2026 / Reg D 506(b) / TX$3.0M
- Arcadia Biosciences, Inc.June 26, 2026 / Reg D 506(b) / TX$11.4M
- Edesa Biotech, Inc.June 26, 2026 / Reg D 506(b)$3.5M
- REGENTIS BIOMATERIALS LTD.June 25, 2026 / Reg D 506(c)$6.5M
- Dravite Therapeutics, Inc.June 24, 2026 / Reg D 506(b) / CA$15.0M
- Tempest Therapeutics, Inc.June 23, 2026 / Reg D 506(b) / CA$4.1M
- AcuraStem IncJune 22, 2026 / Reg D 506(b) / CA$5.0M
- Nuclein, LLCJune 22, 2026 / Reg D 506(b) / TX$11.1M
- ADAPTIN BIO, INC.June 22, 2026 / Reg D 506(b) / NC$4.0M
- DINYA DNA, Inc.June 22, 2026 / Reg D 506(b) / CA$4.3M
- Qlaris Bio, Inc.June 17, 2026 / Reg D 506(b) / MA$3.9M
- Reservoir Neuroscience, Inc.June 17, 2026 / Reg D 506(b) / CA$8.0M
- Pierogi Therapeutics, IncJune 17, 2026 / Reg D 506(b) / PA$4.0M
- CND Life Sciences, Inc.June 16, 2026 / Reg D 506(b) / AZ$6.3M
- Memento Medicines, Inc.June 16, 2026 / Reg D 506(b) / MA$93.0M
- Peptaris, Inc.June 16, 2026 / Reg D 506(b) / PA$4.0M
- Nirrin Technologies, Inc.June 15, 2026 / Reg D 506(b) / MA$9.7M
- Immunis, Inc.June 15, 2026 / Reg D 506(b) / CA$12.0M
- X1 Biotech Inc.June 15, 2026 / Reg D 506(b) / MA$2.0M
- Egg Medical, Inc.June 12, 2026 / Reg D 506(b) / MN$13.0M
- Commense Bio, Inc.June 12, 2026 / Reg D 506(b) / CO$2.7M
- Quince Therapeutics, Inc.June 11, 2026 / Reg D 506(b) / CA$7.4M
- Haku Bio, Inc.June 10, 2026 / Reg D 506(b) / MA$2.5M
- Haku Bio, Inc.June 10, 2026 / Reg D 506(b) / MA$2.7M
- Ovelle Bio Corp.June 10, 2026 / Reg D 506(b) / DE$9.2M
- Duo Oncology Inc.June 9, 2026 / Reg D 506(b) / PA$3.0M
- DesiCorp, Inc.June 9, 2026 / Reg D 506(b) / KY$6.0M
- Biostax Corp.June 8, 2026 / Reg D 506(b) / FL$7.5M
- HCW Biologics Inc.June 8, 2026 / Reg D 506(b) / FL$4.0M
- Spine BioPharma, Inc.June 5, 2026 / Reg D 506(b) / NY$8.5M
- Illuminare Biotechnologies IncJune 4, 2026 / Reg D 506(b) / NY$4.0M
- Entact Bio, Inc.June 3, 2026 / Reg D 506(b) / MA$10.0M
- BioStem Technologies, Inc.June 3, 2026 / Reg D 506(b) / FL$2.5M
- Galaxy Diagnostics, Inc.June 3, 2026 / Reg D 506(b) / NC$5.7M
- Akari Therapeutics PlcJune 3, 2026 / Reg D 506(b) / FL$5.5M
- Biolexis Therapeutics Inc.June 3, 2026 / Reg D 506(b) / UT$12.0M
- iQure Pharma Inc.June 3, 2026 / Reg D 506(b) / NJ$4.0M
- Maxymune Therapeutics, Inc.June 3, 2026 / Reg D 506(b) / CA$4.5M
- Human Biotech, Inc.June 3, 2026 / Reg D 506(b) / MA$10.0M
- Goldenrod Therapeutics, Inc.June 3, 2026 / Reg D 506(b) / TX$6.5M
- Ardego Therapeutics, Inc.June 3, 2026 / Reg D 506(b) / MD$3.0M
- Uniform Bio Inc.June 2, 2026 / Reg D 506(b) / NC$2.7M
- Sangtera Inc.June 1, 2026 / Reg D 506(b) / MA$2.5M